Allez à l'équipe
Geoff Nash
Directeur
Geoff is a director at Oaklins Cavendish, one of Oaklins’ member firms in the UK, and heads its ECM activities. He has over 20 years’ corporate finance experience in growth companies, having advised on all aspects of IPO, M&A and secondary funding. Geoff has advised clients across a range of sectors, with a particular focus on life sciences. His clients include Avacta plc, Synairgen plc, Bioventix plc and Tristel plc.
Prior to joining the team, Geoff qualified with KPMG and previously worked in private equity. He also spent seven years at Evolution Securities (formerly Beeson Gregory and now part of Investec).
Bureau
Londres, Royaume-Uni
Courriel
g.nash@cavendish.oaklins.com
Téléphone bureau
+44 20 7220 0563
Londres, Royaume-Uni
Courriel
g.nash@cavendish.oaklins.com
Téléphone bureau
+44 20 7220 0563
Transactions connexes
Soins de la Santé
CelLBxHealth has completed an oversubscribed US$10.9 million fundraise
En apprendre plus
Soins de la Santé
Oncimmune Holdings plc has placed and converted debt into equity
En apprendre plus
Soins de la Santé
IXICO plc has completed a placing, subscription and retail offer
En apprendre plus
Soins de la Santé
Creo Medical Group plc has completed a US$15.7 million equity fundraise
En apprendre plus
Services Financiers
FRP Advisory Group plc has finalized a successful secondary placing
En apprendre plus
Machinerie Industrielle et Composantes











